#China #Shanghai #healthcare #Medical Imaging #United Imaging

United Imaging Healthcare's Financial Results for Q1-Q3 2026

In a remarkable display of progress, United Imaging Healthcare (688271.SH), a pioneer in advanced medical imaging technologies and intelligent healthcare solutions, has announced its financial performance for the first nine months of 2026. With total revenue reaching approximately RMB 10.58 billion, the company has experienced a commendable increase of 19.43% year-on-year. Additionally, the third quarter alone generated RMB 3.53 billion, while the net profit for shareholders showed a healthy rise of 13%, amounting to RMB 138 million.

International Revenue Surge

One of the most noteworthy aspects of this report is the significant contribution from international markets, which has been a key factor driving United Imaging's growth. In the first three quarters of 2026, revenue from international operations surged to RMB 3.00 billion, marking an impressive increase of 50.30% from the previous year. This international revenue now accounts for 28.31% of the company's total revenue, reflecting a growth of 5.82 percentage points compared to the same period last year.

European and Asia-Pacific Expansion

In Europe, the company has capitalized on its high-end imaging equipment, achieving nearly 30% year-on-year growth in revenue during the first nine months. Through cumulative deliveries exceeding 850 systems, United Imaging's advanced imaging solutions have been deployed across more than half of the European Union member states. The company has established a robust regional presence with a team of over 160 employees dedicated to advancing high-end imaging projects and enhancing local customer support.

The Asia-Pacific region also witnessed remarkable progress, with revenue more than doubling, surpassing 100% year-on-year growth during Q1-Q3 2026. Major installations include high-end MRI systems within Singapore Health Services and an increasing number of PET/CT installations across Australia. Notably, Japan saw the installation of its first uMI Panvivo PET/CT system at Saitama Central Clinic, further evidencing the company's expanding footprint in this lucrative market.

Strengthening the Domestic Market

In China, United Imaging Healthcare has solidified its market position, increasing its share by 2.2 percentage points year-on-year in the first nine months. The array of its product offerings combined with advancements in high-end imaging, interventional systems, and radiotherapy has bolstered its domestic performance.

Regulatory Progress and Intellectual Property Development

The company’s ambitious international expansion continues to be backed by regulatory support and the development of innovative intellectual properties. By September 30, 2026, a total of 170 products had secured approval from China's National Medical Products Administration (NMPA), while 84 had attained CE certification and 79 received U.S. FDA 510(k) clearance. This includes an additional 18 NMPA approvals, 14 CE certifications, and 21 FDA clearances obtained during the reporting period. Furthermore, eight of its products have gained recognition under China’s national innovative medical device program.

With more than 40 AI-enabled medical devices receiving FDA clearance, United Imaging has also established intelligent technology platforms across all its product lines. The company boasts a strong patent portfolio, with cumulative applications exceeding 10,800, where invention patents represent over 80%, and more than 5,700 patents have been granted to date.

A Global Network and Future Outlook

Today, United Imaging Healthcare's systems serve more than 100 countries and regions worldwide, and the company caters to over 17,000 medical and research institutions. Cumulative system deliveries have surpassed 41,000, supported by a global team of more than 1,100 service engineers. Looking to the future, United Imaging Healthcare is committed to enhancing its global operations and service capabilities, aiming to expand access to advanced medical technologies while fostering sustainable growth through continuous innovation.

With such a strong performance and a clear growth strategy in place, United Imaging Healthcare is poised for continued success in the evolving landscape of medical technology.